<DOC>
	<DOCNO>NCT00902252</DOCNO>
	<brief_summary>The purpose clinical study demonstrate Vitala™ Continence Control Device safe effective worn 12 hour per day .</brief_summary>
	<brief_title>Multi-National Phase III Vitala™ 12-Hour Wear Test</brief_title>
	<detailed_description />
	<criteria>Is legal consent age . Is able read , write , understand study , require procedure , study related documentation . Has sign inform consent . Has end colostomy least 12 week duration form semi form effluent . Is able wear Natura® skin barrier wafer flange size 45mm 57 mm . Is willing remove replace skin barrier wafer three day , often desire . Has stoma protrude 2 cm rest . Has demonstrate success wear traditional pouching system . ( Investigator judgment ) Is willing participate trial total 215 day . ( approximately 7 month ) Is willing meet investigator total 12 schedule visit plus additional visit deem necessary investigator . Has ability complete selfcare . Has know skin sensitivity component product test . Has skin rating `` 2 '' great accord Skin Rating Scale . Is receive radiation area pouch system . Is receive chemotherapy stable regimen maintenance chemotherapy . Requires pouch belt wear Vitala Requires convexity moldable skin barrier . Has participate clinical study within past 90 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>